Cargando…
Strategy for Treating Motor Neuron Diseases Using a Fusion Protein of Botulinum Toxin Binding Domain and Streptavidin for Viral Vector Access: Work in Progress
Although advances in understanding of the pathogenesis of amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) have suggested attractive treatment strategies, delivery of agents to motor neurons embedded within the spinal cord is problematic. We have designed a strategy based on the...
Autores principales: | Drachman, Daniel B., Adams, Robert N., Balasubramanian, Uma, Lu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153189/ https://www.ncbi.nlm.nih.gov/pubmed/22069580 http://dx.doi.org/10.3390/toxins2122872 |
Ejemplares similares
-
Botulinum toxin in the management of acquired motor fusion deficiency
por: Murthy, Ramesh, et al.
Publicado: (2009) -
Internalization of novel non-viral vector TAT-streptavidin into human cells
por: Rinne, Johanna, et al.
Publicado: (2007) -
Botulinum toxin in the management of acquired motor fusion deficiency: The missing links
por: Pandey, Pramod Kumar, et al.
Publicado: (2010) -
Streptavidin-Saporin: Converting Biotinylated Materials into Targeted Toxins
por: Ancheta, Leonardo R., et al.
Publicado: (2023) -
Support Vector Machine Classification of Streptavidin-Binding Aptamers
por: Yu, Xinliang, et al.
Publicado: (2014)